Report ID: UCMIG35H2148
Report ID:
UCMIG35H2148 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
In 2021, the global AI in oncology market demonstrated a significant valuation of USD 577.5 million. This growth can be attributed to various factors, such as the increasing prevalence of cancer, the need for more efficient and accurate diagnostic and treatment solutions, and advancements in artificial intelligence technology. The adoption of AI in oncology has the potential to revolutionize cancer care by aiding in early detection, personalized treatment planning, and improved patient outcomes, driving the market's continued expansion in the coming years.
This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.
Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.
The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Biotechnology by segment aggregation, the contribution of the Biotechnology in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.
To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONThe market for AI In Oncology was estimated to be valued at US$ XX Mn in 2021.
The AI In Oncology Market is estimated to grow at a CAGR of XX% by 2028.
The AI In Oncology Market is segmented on the basis of Component, Cancer Type, Treatment Type, Region.
Based on region, the AI In Oncology Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the AI In Oncology Market are , Azra AI, IBM, Siemens Healthineers, Intel, GE Healthcare, NVIDIA, Digital Diagnostics Inc., Concert.AI, Median Technologies, Path AI.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: UCMIG35H2148